Narrowing range ahead as vaccination hits critical mass, no more flashy stimulus/vaccine/recovery "hopes" headlines, exhaustion top likely around 430, and bubbly valuations could result in shocking pullback to 310-15 in second half of the year.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.